Request for Notification From Industry Organizations Interested in Participating in Selection Process for Nonvoting Industry Representatives on Public Advisory Committees and Request for Nominations for Nonvoting Industry Representatives on Public Advisory Committees, 54589-54590 [E9-25407]

Download as PDF Federal Register / Vol. 74, No. 203 / Thursday, October 22, 2009 / Notices Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Lawrence E. Boerboom, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5156, MSC 7814, Bethesda, MD 20892, (301) 435– 8367, boerboom@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 14, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–25405 Filed 10–21–09; 8:45 am] Contact Person: Ross D. Shonat, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5156, MSC 7849, Bethesda, MD 20892, 301–435– 2786, shonatr@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 15, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–25471 Filed 10–21–09; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Center for Scientific Review; Notice of Closed Meetings dcolon on DSK2BSOYB1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; ARRA AREA Special Emphasis Panel 07. Date: November 17, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Beacon Hotel and Corporate Quarters, 1615 Rhode Island Avenue, NW., Washington, DC 20036. Contact Person: Rolf Menzel, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3196, MSC 7808, Bethesda, MD 20892, 301–435– 0952, menzelro@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–OD– 09–008 BRDG–SPAN and RFA–OD–09–009 Catalyst ARRA Review Panel 8. Date: November 23, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: The Fairmont Washington, DC, 2401 M Street, NW., Washington, DC 20037. 15:13 Oct 21, 2009 Jkt 220001 three background papers that will support the development of NCCAM’s third strategic plan. Comments may be provided through the NCCAM Web site at https://nccam.nih.gov. For Further Information: To request more information, visit the NCCAM Web site at https://nccam.nih.gov, call 1–888–644–6226, or e-mail <ncamsp@mail.nih.gov> Comments Due Date: Comments regarding the draft of NCCAM’s strategic plan are best assured of having their full effect if received by November 19, 2009. Dated: October 13, 2009. Jack Killen, Deputy Director, National Center for Complementary and Alternative Medicine, National Institutes of Health. [FR Doc. E9–25307 Filed 10–21–09; 8:45 am] BILLING CODE 4140–01–M National Institutes of Health National Institutes of Health VerDate Nov<24>2008 54589 Request for Comment: National Center for Complementary and Alternative Medicine Announcement of Strategic Planning Background Papers ACTION: Notice. The National Center for Complementary and Alternative Medicine (NCCAM) is developing its third strategic plan and invites the public to provide comments on three background papers which will support the development of this plan. The papers will cover three topics: Mission, priority setting, and communications and decisionmaking. They will be publicly available through the NCCAM Web site at from on or about October 19 through November 19, 2009. The public is invited to provide comments through the NCCAM Web site. Background: The National Center for Complementary and Alternative Medicine (NCCAM) was established in 1998 with the mission of exploring complementary and alternative healing practices in the context of rigorous science, training CAM researchers, and disseminating authoritative information to the public and professionals. To date, NCCAM’s efforts to rigorously study CAM, to train CAM researchers, and to communicate with the public and professionals, have been guided by NCCAM’s previous strategic plans, located on the NCCAM Web site at https://nccam.nih.gov/about/plans. The public is invited to review the background papers and provide comments from October 15 through November 15, 2009. The papers may be viewed at https://nccam.nih.gov/. Request For Comments: The public is invited to provide comments on the SUMMARY: PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0664] Request for Notification From Industry Organizations Interested in Participating in Selection Process for Nonvoting Industry Representatives on Public Advisory Committees and Request for Nominations for Nonvoting Industry Representatives on Public Advisory Committees AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is requesting that any industry organizations interested in participating in the selection of nonvoting industry representatives to serve on its public advisory committees for the Center for Food Safety and Applied Nutrition (CFSAN) notify FDA in writing. FDA is also requesting nominations for nonvoting industry representatives to serve on CFSAN’s Food Advisory Committee. A nominee may either be self-nominated or nominated by an organization to serve as a nonvoting industry representative. Nominations will be accepted for current vacancies effective with this notice. DATES: Any industry organization interested in participating in the selection of an appropriate nonvoting member to represent industry interests must send a letter stating that interest to FDA by November 23, 2009, for vacancies listed in this notice. Concurrently, nomination materials for E:\FR\FM\22OCN1.SGM 22OCN1 54590 Federal Register / Vol. 74, No. 203 / Thursday, October 22, 2009 / Notices prospective candidates should be sent to FDA by November 23, 2009. ADDRESSES: All letters of interest and nominations should be submitted in writing to Carolyn Jeletic (see FOR FURTHER INFORMATION CONTACT). FOR FURTHER INFORMATION CONTACT: Carolyn Jeletic, Center for Food Safety and Applied Nutrition, Office of Regulations, Policy, and Social Sciences (HFS–024), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 301– 436–1913, carolyn.jeletic@fda.hhs.gov. SUPPLEMENTARY INFORMATION: I. Selection Procedure Any industry organization interested in participating in the selection of an appropriate nonvoting member to represent industry interests should send a letter stating that interest to the FDA contact (see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of this document (see DATES). Within the subsequent 30 days, FDA will send a letter to each organization that has expressed an interest, attaching a complete list of all such organizations, and a list of all nominees along with their current resumes. The letter will also state that it is the responsibility of the interested organizations to confer with one another and to select a candidate, within 60 days after the receipt of the FDA letter, to serve as the nonvoting member to represent industry interests for a particular committee. The interested organizations are not bound by the list of nominees in selecting a candidate. However, if no individual is selected within 60 days, the Commissioner of Food and Drugs will select the nonvoting member to represent industry interests. dcolon on DSK2BSOYB1PROD with NOTICES II. Application Procedure Individuals may self nominate and/or an organization may nominate one or more individuals to serve as a nonvoting industry representative. A current curriculum vitae and the name of the committee of interest should be sent to the FDA contact person within the 30 days. FDA will forward all nominations to the organizations expressing interest in participating in the selection process for the committee. (Persons who nominate themselves as nonvoting industry representatives will not participate in the selection process). FDA has a special interest in ensuring that women, minority groups, individuals with physical disabilities, and small businesses are adequately represented on its advisory committees, and therefore, encourages, nominations for appropriately qualified candidates VerDate Nov<24>2008 15:13 Oct 21, 2009 Jkt 220001 from these groups. Specifically, in this document, nominations for nonvoting representatives of industry interests are encouraged from the food production and manufacturing and industry, the dietary supplement manufacturing industry, the agricultural biotechnology manufacturing industry. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees. Dated: October 16, 2009. David Horowitz, Assistant Commissioner for Policy. [FR Doc. E9–25407 Filed 10–21–09; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Docket ID: FEMA–2009–0001] Agency Information Collection Activities: Submission for OMB Review; Comment Request, OMB No. 1660–0099 AGENCY: Federal Emergency Management Agency, DHS. ACTION: Notice; 30-day notice and request for comments; revision of a currently approved information collection; OMB No. 1660–0099; FEMA Form 646–0, Citizen Corps Individual Registration. SUMMARY: The Federal Emergency Management Agency (FEMA) has submitted the information collection abstracted below to the Office of Management and Budget for review and clearance in accordance with the requirements of the Paperwork Reduction Act of 1995. The submission describes the nature of the information collection, the categories of respondents, the estimated burden (i.e., the time, effort and resources used by respondents to respond) and cost, and the actual data collection instruments FEMA will use. DATES: Comments must be submitted on or before November 23, 2009. ADDRESSES: Submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget. Comments should be addressed to the Desk Officer for the Department of Homeland Security, Federal Emergency Management Agency, and sent via electronic mail to PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 oira.submission@omb.eop.gov or faxed to (202) 395–5806. FOR FURTHER INFORMATION CONTACT: Requests for additional information or copies of the information collection should be made to Director, Office of Records Management, 1800 South Bell Street, Arlington, VA 20598–3005, facsimile number (202) 646–3347, or e-mail address FEMA–InformationCollections@dhs.gov. SUPPLEMENTARY INFORMATION: Collection of Information Title: Citizen Corps Individual Registration. Type of information collection: Revision of a currently approved information collection. OMB Number: OMB No. 1660–0099. Form Titles and Numbers: FEMA Form 646–0, Citizen Corps Individual Registration. Abstract: FEMA’s Community Preparedness Division (CPD) would like to revise a currently approved collection for its individual registration to allow members of the public to provide contact information to receive national programmatic updates and announcements such as upcoming preparedness demonstrations and training opportunities and the opportunity to get involved in local organizations and events. Affected Public: Individuals or households. Estimated Number of Respondents: 20,000. Frequency of Response: Once. Estimated Average Hour Burden per Respondent: .08 burden hours. Estimated Total Annual Burden Hours: 1,600 burden hours. Estimated Cost: None. Daisy Mitchell, Acting Director, Records Management Division, Office of Management, Federal Emergency Management Agency, Department of Homeland Security. [FR Doc. E9–25378 Filed 10–21–09; 8:45 am] BILLING CODE 9111–05–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Docket ID: FEMA–2009–0001; OMB No. 1660–0098] Agency Information Collection Activities: Submission for OMB Review; Comment Request AGENCY: Federal Emergency Management Agency, DHS. E:\FR\FM\22OCN1.SGM 22OCN1

Agencies

[Federal Register Volume 74, Number 203 (Thursday, October 22, 2009)]
[Notices]
[Pages 54589-54590]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-25407]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0664]


Request for Notification From Industry Organizations Interested 
in Participating in Selection Process for Nonvoting Industry 
Representatives on Public Advisory Committees and Request for 
Nominations for Nonvoting Industry Representatives on Public Advisory 
Committees

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is requesting that any 
industry organizations interested in participating in the selection of 
nonvoting industry representatives to serve on its public advisory 
committees for the Center for Food Safety and Applied Nutrition (CFSAN) 
notify FDA in writing. FDA is also requesting nominations for nonvoting 
industry representatives to serve on CFSAN's Food Advisory Committee. A 
nominee may either be self-nominated or nominated by an organization to 
serve as a nonvoting industry representative. Nominations will be 
accepted for current vacancies effective with this notice.

DATES: Any industry organization interested in participating in the 
selection of an appropriate nonvoting member to represent industry 
interests must send a letter stating that interest to FDA by November 
23, 2009, for vacancies listed in this notice. Concurrently, nomination 
materials for

[[Page 54590]]

prospective candidates should be sent to FDA by November 23, 2009.

ADDRESSES:  All letters of interest and nominations should be submitted 
in writing to Carolyn Jeletic (see FOR FURTHER INFORMATION CONTACT).

FOR FURTHER INFORMATION CONTACT: Carolyn Jeletic, Center for Food 
Safety and Applied Nutrition, Office of Regulations, Policy, and Social 
Sciences (HFS-024), Food and Drug Administration, 5100 Paint Branch 
Pkwy., College Park, MD 20740, 301-436-1913, 
carolyn.jeletic@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Selection Procedure

    Any industry organization interested in participating in the 
selection of an appropriate nonvoting member to represent industry 
interests should send a letter stating that interest to the FDA contact 
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of 
this document (see DATES). Within the subsequent 30 days, FDA will send 
a letter to each organization that has expressed an interest, attaching 
a complete list of all such organizations, and a list of all nominees 
along with their current resumes. The letter will also state that it is 
the responsibility of the interested organizations to confer with one 
another and to select a candidate, within 60 days after the receipt of 
the FDA letter, to serve as the nonvoting member to represent industry 
interests for a particular committee. The interested organizations are 
not bound by the list of nominees in selecting a candidate. However, if 
no individual is selected within 60 days, the Commissioner of Food and 
Drugs will select the nonvoting member to represent industry interests.

II. Application Procedure

    Individuals may self nominate and/or an organization may nominate 
one or more individuals to serve as a nonvoting industry 
representative. A current curriculum vitae and the name of the 
committee of interest should be sent to the FDA contact person within 
the 30 days. FDA will forward all nominations to the organizations 
expressing interest in participating in the selection process for the 
committee. (Persons who nominate themselves as nonvoting industry 
representatives will not participate in the selection process).
    FDA has a special interest in ensuring that women, minority groups, 
individuals with physical disabilities, and small businesses are 
adequately represented on its advisory committees, and therefore, 
encourages, nominations for appropriately qualified candidates from 
these groups. Specifically, in this document, nominations for nonvoting 
representatives of industry interests are encouraged from the food 
production and manufacturing and industry, the dietary supplement 
manufacturing industry, the agricultural biotechnology manufacturing 
industry.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: October 16, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-25407 Filed 10-21-09; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.